The Bone Metastasis market is benefiting from advances in radiopharmaceuticals designed for selected patients with bone metastases. These treatments can deliver radiation to targeted sites and provide additional options in particular cancer settings, supporting continued research and development in nuclear medicine. The Bone Metastasis Market was valued at US$ 20.49 billion in 2025 and is...